Global /India /Healthcare /Drug Manufacturers - Specialty & Generic /PPLPHARMA
chevron_leftBack

Piramal Pharma Ltd.

PPLPHARMA
NSE: PPLPHARMA Delayed
223.62INR -0.4%
2.62 USD
As of 24 April 2025, Piramal Pharma Ltd. has a market cap of $3.49B USD, ranking #3704 globally and #253 in India. It ranks #314 in the Healthcare sector, and #54 in the Drug Manufacturers - Specialty & Generic industry.
Global Rank
3704
Country Rank
253
Sector Rank
314
Industry Rank
54
Key Stats
Market Cap
$3.49BUSD
297.58B INR
Enterprise Value
$3.99BUSD
341.36B INR
Revenue (TTM)
$1.05BUSD
89.49B INR
EBITDA (TTM)
$160.35MUSD
13.71B INR
Net Income (TTM)
$4.56MUSD
389.0M INR
EBITDA Margin
15%
Profit Margin
0.4%
PE Ratio
765.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
6,719
Founded
2020
Website
piramalpharma.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-0.4% 0.9% -1% -6.8% -1.6% 61%
Upcoming Earnings
Earnings Date
Fri, May 9

Markets

Exchange Ticker Price
National Stock Exchange of India
MIC: XNSE
PRIMARY
PPLPHARMA
Piramal Pharma Ltd
ISIN: INE0DK501011
Shares Out.:
1.326B1 Shares Float: 618.106M2
TV:
SA:
YF:
GF:
BA:
MS:
223.62 INR
Bombay Stock Exchange
MIC: XBOM
543635 (PPLPHARMA)
Piramal Pharma Ltd
ISIN: INE0DK501011
TV:
SA:
YF:
GF:
BA:
MS:
220.15 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Piramal Pharma Ltd.

Piramal Pharma Limited operates as a pharmaceutical company in North America, Europe, Japan, India, and internationally. The company offers a portfolio of pharmaceutical products and services through global development and manufacturing facilities and distribution network. It also operates contract development and manufacturing organization that provides services across the spectrum of the drug life cycle, including discovery, development, and commercial manufacturing of drug substances and products; complex hospital generics business which offers inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, and other generic and specialty products; and India consumer healthcare business comprising analgesics, skin care, vitamin/mineral supplement, kids’ wellness, digestives, women’s health, and hygiene and protection. The company was incorporated in 2020 and is based in Mumbai, India.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (India)
Name
Market Cap diff.
Sun Pharmaceutical Industries Ltd.
SUNPHARMA
$49.13B
4.19T INR
1K%
Divi's Laboratories Ltd.
DIVISLAB
$18.39B
1.57T INR
427%
Cipla Ltd.
CIPLA
$14.46B
1.23T INR
315%
Torrent Pharmaceuticals Ltd.
TORNTPHARM
$13.23B
1.13T INR
279%
Mankind Pharma Ltd.
MANKIND
$12.47B
1.06T INR
258%
Industry: Drug Manufacturers - Specialty & Generic (Global)
Name
Market Cap diff.
Zoetis Inc.
ZTS
$67.32B
2K%
Merck KGaA
MRK
$59.42B
52.43B EUR
2K%
Takeda Pharmaceutical Company Ltd.
4502
$46.31B
6.6T JPY
1K%
Haleon plc
HLN
$45.57B
34.34B GBP
1K%
Galderma Group AG
GALD
$23.06B
19.13B CHF
561%